Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor-Reference-Cited by-同舟云学术

Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor

Published:2002-04 Issue:2 Volume:39 Page:134-140
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Cottle Tammy E.,Fier Carol J.,Donadieu Jean,Kinsey Sally E.

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Clinical efficacy of recombinant human granulocyte colony stimulating factor (r-metHuG-CSF) in patients with severe chronic neutropenia;Bonilla;Blood,1990

2. Long-term safety of treatment with recombinant human granulocytic colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias;Bonilla;Br J Haematol,1994

3. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis;Bonilla;N Engl J Med,1989

4. Administration of r-metHuG-CSF during pregnancy in patients with severe chronic neutropenia (SCN);Boxer;Blood,1995

5. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia;Boxer;Clin Immunol Immunopathol,1992

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC);Annals of Oncology;2023-10

3. Cyclic neutropenia and concomitant IgA nephropathy: a case report;BMC Nephrology;2023-05-03

4. Pregnancy-associated breast cancer: does timing of presentation affect outcome?;Breast Cancer Research and Treatment;2023-01-20

5. Administration of G-CSF for PBSC collection may unmask pre-existing IgA-nephropathy: A case report;Journal of Clinical Nephrology;2022-09-14